| Mobile phones: Reservoirs for the transmission of nosocomial pathogens S Pal, D Juyal, S Adekhandi, M Sharma, R Prakash, N Sharma, A Rana, ... Advanced biomedical research 4 (1), 144, 2015 | 129 | 2015 |
| Somatostatin Receptor Imaging and Theranostics: Current Practice and Future Prospects S Park, AS Parihar, L Bodei, TA Hope, N Mallak, C Millo, K Prasad, ... Journal of Nuclear Medicine 62 (10), 1323-1329, 2021 | 35 | 2021 |
| 68Ga-DOTA-RGD2 Positron Emission Tomography/Computed Tomography in Radioiodine Refractory Thyroid Cancer: Prospective Comparison of Diagnostic Accuracy with … AS Parihar, BR Mittal, R Kumar, J Shukla, A Bhattacharya Thyroid 30 (4), 557-567, 2020 | 29 | 2020 |
| Novel use of 177Lu-DOTA-RGD2 in treatment of 68Ga-DOTA-RGD2-avid lesions in papillary thyroid cancer with TENIS. AS Parihar, A Sood, R Kumar, P Bhusari, J Shukla, BR Mittal European journal of nuclear medicine and molecular imaging, 2018 | 26 | 2018 |
| 68Ga-PSMA-HBED-CC-Avid Synchronous Urinary Bladder Paraganglioma in a Patient With Metastatic Prostate Carcinoma. AS Parihar, SK Vadi, BR Mittal, R Kumar, A Bal, SK Singh Clinical nuclear medicine 43 (9), e329-e330, 2018 | 22 | 2018 |
| Unusual Case of Diffuse Penile Metastasis of Prostate Cancer on 68Ga PSMA PET/CT Imaging and 177Lu PSMA Posttherapy Scintigraphy. SK Vadi, R Kumar, BR Mittal, AS Parihar, SK Singh Clinical nuclear medicine 43 (4), 276-278, 2018 | 20 | 2018 |
| 68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma. AS Parihar, BR Mittal, A Sood, RK Basher, G Singh Clinical nuclear medicine 43 (11), e414-e416, 2018 | 19 | 2018 |
| Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy AS Parihar, K Chandekar, H Singh, A Sood, BR Mittal Asia Oceania Journal of Nuclear Medicine and Biology 9 (1), 67-70, 2021 | 16 | 2021 |
| 18F-FDG PET/CT in Tuberculosis: Can Interim PET/CT Predict the Clinical Outcome of the Patients? A Sood, BR Mittal, M Modi, R Chhabra, R Verma, N Rana, AS Parihar, ... Clinical Nuclear Medicine 45 (4), 276-282, 2020 | 16 | 2020 |
| Imaging-Guided Use of Combined 177Lu-DOTATATE and Capecitabine Therapy in Metastatic Mediastinal Paraganglioma AG Ashwathanarayana, CK Biswal, A Sood, AS Parihar, R Kapoor, ... Journal of nuclear medicine technology 45 (4), 314-316, 2017 | 16 | 2017 |
| 68Ga-PSMA-HBED-CC PET/CT and 18F-FDG PET/CT in Ewing Sarcoma. AS Parihar, A Sood, BR Mittal, R Kumar, H Singh, SS Dhatt Clinical Nuclear Medicine 45 (1), e57-e58, 2020 | 15 | 2020 |
| FDG PET/CT–based Response Assessment in Malignancies AS Parihar, F Dehdashti, RL Wahl RadioGraphics 43 (4), e220122, 2023 | 14 | 2023 |
| Nephrotoxicity after radionuclide therapies AS Parihar, S Chopra, V Prasad Translational Oncology 15 (1), 101295, 2022 | 14 | 2022 |
| 68Ga DOTA-Exendin PET/CT for Detection of Insulinoma in a Patient With Persistent Hyperinsulinemic Hypoglycemia. AS Parihar, SK Vadi, R Kumar, BR Mittal, H Singh, A Bal, R Walia, ... Clinical nuclear medicine 43 (8), e285-e286, 2018 | 14 | 2018 |
| Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera … B Singh, S Sharma, P Bansal, M Hooda, H Singh, AS Parihar, A Kumar, ... Nuclear Medicine Communications 42 (5), 482-489, 2021 | 13 | 2021 |
| IgG4-Related Disease Simulating Carcinoma Colon With Diffuse Peritoneal Carcinomatosis on 18F-FDG PET/CT. SK Vadi, AS Parihar, R Kumar, H Singh, BR Mittal, A Bal, SK Sinha Clinical nuclear medicine 43 (7), e247-e249, 2018 | 13 | 2018 |
| Evaluation of recurrent parathyroid carcinoma: A new imaging tool in uncommon entity NTK Thanseer, AS Parihar, A Sood, SK Bhadada, D Dahiya, P Singh, ... World Journal of Nuclear Medicine 18 (2), 198, 2019 | 12 | 2019 |
| Response to concomitant enzalutamide and 177Lu-PSMA-617 radioligand therapy in ATM-mutated metastatic castration resistant prostate cancer S Satapathy, CK Das, AS Parihar, A Sood, BR Mittal Clinical nuclear medicine 46 (7), 582-583, 2021 | 11 | 2021 |
| Diagnostic and prognostic value of 18F-FDG PET/CT imaging in suspected recurrence of male breast cancer SK Vadi, BR Mittal, A Sood, G Singh, A Bal, AS Parihar, A Bhattacharya, ... Nuclear medicine communications 40 (1), 63-72, 2019 | 10 | 2019 |
| Pancreatic Malignancy or Not?: Role of 18F-FDG PET/CT in Solving the Diagnostic Dilemma and Evaluating Treatment Response. AS Parihar, H Singh, R Kumar, V Gupta, BR Mittal Clinical nuclear medicine 43 (4), e115-e117, 2018 | 10 | 2018 |
Bhagwant Rai MittalProfessor of Nuclear MedicineVerified email at pgimer.edu.in
